{{Rsnum
|rsid=2607737
|Gene=XPC
|Chromosome=3
|position=14151668
|Orientation=plus
|GMAF=0.4536
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=XPC
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 24.8 | 52.2 | 23.0
| HCB | 48.9 | 44.5 | 6.6
| JPT | 61.1 | 37.2 | 1.8
| YRI | 23.8 | 44.9 | 31.3
| ASW | 28.1 | 49.1 | 22.8
| CHB | 48.9 | 44.5 | 6.6
| CHD | 46.8 | 43.1 | 10.1
| GIH | 33.7 | 51.5 | 14.9
| LWK | 13.6 | 44.5 | 41.8
| MEX | 19.0 | 53.4 | 27.6
| MKK | 9.0 | 35.9 | 55.1
| TSI | 30.4 | 47.1 | 22.5
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2607737
|Name_s=rs2607737 T/C XPC
|Gene_s=XPC
|Feature=
|Evidence=PubMed ID:20157331
|Annotation=Risk or phenotype-associated allele: Not specified. Phenotype: This SNP was associated with clearance of docetaxel. Study size: 31. Study population/ethnicity: Patients with Non-Small-Cell Lung Carcinoma. Significance metric(s): p = 0.3743 (ANOVA); p = 0.6323 (QMIS); p < 0.000001 (KW) Type of association: PK.
|Drugs=docetaxel
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA165291800
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2607737
|overall_frequency_n=50
|overall_frequency_d=128
|overall_frequency=0.390625
|n_genomes=32
|n_genomes_annotated=0
|n_haplomes=44
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}